EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cerevisterol from Ophiocordyceps sinensis fruiting bodies against liver fibrosis

Minting Yang, Tao Sun, Richou Han, Huichun Xie, Li Cao

Frontiers in Pharmacology · 08.07.2026 · 17

DOI: 10.3389/fphar.2026.1825109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 08.07.2026. Verfasst von Minting Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Qinghai Normal University, Xining, China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Liver fibrosis is a critical pathological process to irreversible cirrhosis. The valued Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones and Spatafora (Ophiocordycipitaceae, Hypocreales) fungus exhibits remarkable hepatoprotective effects, especially anti-inflammation. However, detailed metabolites with anti-inflammation activity need to be explored from this fungus. This study investigates the anti-liver fibrosis effect of cerevisterol extracted from O. sinensis fruiting bodies on TGF-β1-induced LX-2 cells (a human hepatic stellate cell line) and the underlying potential mechanisms.

Methods

The metabolites were extracted and purified by petroleum ether, ethanol reflux extraction and chromatographic separation technology. Their structures were identified based on extensive NMR and MS data. TGF-β1-induced LX-2 cells were employed to study the anti-inflammation activity of the isolated cerevisterol. The mRNA expression of Smad3, Smad4 , and Collagen I in the cells was verified by qRT-PCR and Smad3 and Smad4 proteins by Western blot.

Results

Cerevisterol, adenosine, uridine, ergosterol, 2-piperidone, L-tryptophan and (24S)-ergost-7(8)-en-3β,5α,6β-triol were obtained. In the TGF-β1-induced fibrosis model, cerevisterol (10 μM) and a commercial anti-liver fibrosis drug containing Chinese cordyceps (75 ng/mL) as positive control significantly suppressed cell proliferation at 72 and 96 hours. qRT-PCR analysis demonstrated that cerevisterol downregulated mRNA expression of Smad3, Smad4, and Collagen I. Western blot results confirmed reduced protein levels of Smad3 and Smad4 in the cerevisterol-treated cells.

Discussion

Cerevisterol from O. sinensis fungus exerts anti-liver fibrosis effects by inhibiting hepatic stellate cell activation and proliferation, and by downregulating TGF-β/Smad3 signaling pathway, thereby reducing excessive extracellular matrix-related gene and protein expression.

Schlagwörter

Stichwörter der Autor:innen

LX-2 cellsOphiocordyceps sinensisTGF-β1cerevisterolliver fibrosis

Autor:innen und Institutionen

  • Qinghai Normal University, Xining, China.
  • Guangdong Key Laboratory of Animal Conservation and Resource Utilization, Guangdong Public Laboratory of Wild Animal Conservation and Utilization, Institute of Zoology, Guangdong Academy of Sciences, Guangzhou, China.

Zitieren

APA

Yang, M., Sun, T., Han, R., Xie, H., & Cao, L. (2026). Cerevisterol from Ophiocordyceps sinensis fruiting bodies against liver fibrosis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1825109

Vancouver

Yang M, Sun T, Han R, Xie H, Cao L. Cerevisterol from Ophiocordyceps sinensis fruiting bodies against liver fibrosis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1825109

BibTeX
@article{Yang2026,
  author = {Yang, Minting and Sun, Tao and Han, Richou and Xie, Huichun and Cao, Li},
  title = {Cerevisterol from Ophiocordyceps sinensis fruiting bodies against liver fibrosis},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1825109}
}
Kostenlos starten →